Rexahn Pharmaceuticals - 47 Year Dividend Yield History | RNN

Historical dividend payout and yield for Rexahn Pharmaceuticals (RNN) since 1971. The current TTM dividend payout for Rexahn Pharmaceuticals (RNN) as of November 16, 2018 is $0.00. The current dividend yield for Rexahn Pharmaceuticals as of November 16, 2018 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.041B $0.000B
REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.735B 13.99
Gilead Sciences (GILD) United States $89.518B 10.78
Bio-Techne Corp (TECH) United States $6.051B 40.88